El próximo 30 de enero, la sede de la Universidad de Navarra en Madrid será el punto de encuentro para debatir sobre las barreras a la innovación y los desafíos que enfrentan las startups en el se...
Read more
Sycai Medical software characterizes lesions which enables early diagnosis and automates patient monitoring. For oncologic patients under treatment, it helps healthcare professionals to better underst...
Read more
The transaction includes the participation of Enantia’s management team as shareholders, reinforcing their commitment to the company’s future. The collaboration between Enantia and Inveready will ...
Read more
Maite Fibla: “The startups in our portfolio have increased their revenues by 192% and created more than 229 jobs in the last year. This shows that changing the world and generating economic wealth i...
Read more
Since its founding in 2017, ZYMVOL has established itself as a leader in computational enzyme discovery and design. The company collaborates with the R&D teams of some of the world’s largest compani...
Read more
Augustine Therapeutics, focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enz...
Read more
The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial
Read more
When a company, especially in its early stages, needs investment, there are different legal and financial tools to raise funding. Two of the most commonly used are the convertible note and the capital...
Read more
Nature, the world's leading scientific journal, has spotlighted three Barcelona-based biotech startups, Ona Therapeutics, Nuage Therapeutics, and SpliceBio, in a recent article highlighting Spain's bu...
Read more
Proceeds from the Series C will be deployed to finalize clinical validation and expedite the regulatory approval process of deepull’s UllCORE diagnostic system, which received Breakthrough Device De...
Read more
ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced the successful closing of a $65 million Series A financing round. The...
Read more
This financial contribution will enable the Catalan biotech company to advance the development of new drugs targeting therapeutic targets traditionally considered intractable, such as intrinsically di...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
